Aurora Cannabis Inc. ( ACB) - Key Metrics
ACB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $1.10 | -$0.07 | -$0.07 | -$0.16 |
| 2026Q4 | $0.66 | -$0.99 | $0 | -$0.09 |
| 2026Q3 | $1.66 | $0.03 | $0.30 | $0.19 |
| 2026Q2 | $1.65 | -$0.94 | -$0.74 | -$0.85 |
| 2026Q1 | $1.61 | $0.58 | $0.18 | $0.09 |
ACB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -15.14 |
| 2026Q4 | 0% | -1.15 |
| 2026Q3 | 0% | 45.10 |
| 2026Q2 | 0% | -2.28 |
| 2026Q1 | 0% | -4.00 |
ACB
Price: $3.92
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 13.9 million
Market Capitalization: 244.7 million